These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1378045)

  • 1. LY 186655, a phosphodiesterase inhibitor, inhibits histamine release from human basophils, lung and skin fragments.
    Louis R; Bury T; Corhay JL; Radermecker M
    Int J Immunopharmacol; 1992 Feb; 14(2):191-4. PubMed ID: 1378045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline.
    Louis RE; Radermecker MF
    Int Arch Allergy Appl Immunol; 1990; 92(4):329-33. PubMed ID: 1707400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
    Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
    Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
    Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
    Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin inhibits the release of histamine from human basophils and mast cells.
    Marone G; Columbo M; Triggiani M; Vigorita S; Formisano S
    Agents Actions; 1986 Apr; 18(1-2):96-9. PubMed ID: 2425602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC; Anderson N; Peachell PT
    Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol.
    Marone G; Ambrosio G; Bonaduce D; Genovese A; Triggiani M; Condorelli M
    Int Arch Allergy Appl Immunol; 1984; 74(4):356-61. PubMed ID: 6203844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of R59022, an inhibitor of diacylglycerol kinase, on IgE-mediated histamine release from human lung mast cells and basophils.
    O'Keefe KL; Warner JA
    Agents Actions; 1994 Nov; 43(1-2):1-6. PubMed ID: 7537937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells.
    Okayama Y; Brzezińska-Błaszczyk E; Kuna P; Kaplan AP; Church MK
    Clin Exp Allergy; 1995 Sep; 25(9):890-5. PubMed ID: 8564728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enprofylline and theophylline on purified human basophils.
    Toll JB; Andersson RG
    Allergy; 1984 Oct; 39(7):515-20. PubMed ID: 6208806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenoterol, a selective beta 2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release.
    Morita Y; Miyamoto T
    Allergy; 1987 Oct; 42(7):524-8. PubMed ID: 2446520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE-inhibitor-induced enhancement of spontaneous and IgE-mediated histamine release from mast cells and basophilic leukocytes and the modulatory effect of capsaicin sensitive nerves.
    Lindgren BR; Persson K; Kihlström JE; Andersson RG
    Pharmacol Toxicol; 1989 Feb; 64(2):159-64. PubMed ID: 2474161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant stem cell factor on human skin and lung mast cells and basophil leukocytes.
    Frenz AM; Gibbs BF; Pearce FL
    Inflamm Res; 1997 Feb; 46(2):35-9. PubMed ID: 9085141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release.
    Ebertz JM; Hermens JM; McMillan JC; Uno H; Hirshman C; Hanifin JM
    Agents Actions; 1986 Aug; 18(5-6):455-62. PubMed ID: 2429525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.
    Marone G; Columbo M; Triggiani M; Cirillo R; Genovese A; Formisano S
    Biochem Pharmacol; 1987 Jan; 36(1):13-20. PubMed ID: 2432900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IgE-mediated histamine release from human leukocytes by a new xanthine derivative, D 4026.
    Petersson BA; Svedinger I; Bohlinder K
    Agents Actions; 1980 Nov; 10(5):403-10. PubMed ID: 6163338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IgE-mediated histamine release from human peripheral leukocytes by selective phosphodiesterase inhibitors.
    Kleine-Tebbe J; Wicht L; Gagné H; Friese A; Schunack W; Schudt C; Kunkel G
    Agents Actions; 1992 Jul; 36(3-4):200-6. PubMed ID: 1382373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.